We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
-0.27%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$3.92B
AUM Growth
+$75.1M
Cap. Flow
+$135M
Cap. Flow %
3.46%
Top 10 Hldgs %
32.39%
Holding
6,700
New
1,026
Increased
2,252
Reduced
2,490
Closed
691

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$19.9M
2
SOXX icon
iShares Semiconductor ETF
SOXX
+$19M
3
EFA icon
iShares MSCI EAFE ETF
EFA
+$18.2M
4
CRM icon
Salesforce
CRM
+$16.1M
5
TSLA icon
Tesla
TSLA
+$14.7M

Sector Composition

Rank Sector Weight
1 Technology 18.5%
2 Consumer Discretionary 8.04%
3 Healthcare 7.14%
4 Communication Services 6.4%
5 Financials 6.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OXY.WS icon
6051
Occidental Petroleum Corp Warrants
OXY.WS
$32B
$0 ﹤0.01%
1
PALI icon
6052
Palisade Bio
PALI
$367M
-1
Closed -$4K
PAVE icon
6053
Global X US Infrastructure Development ETF
PAVE
$14.4B
-41,378
Closed -$1.06M
PDLB icon
6054
Ponce Financial Group
PDLB
$485M
-827
Closed -$8K
PDP icon
6055
Invesco Dorsey Wright Momentum ETF
PDP
$1.5B
-5,633
Closed -$505K
PDO
6056
PIMCO Dynamic Income Opportunities Fund
PDO
$1.86B
-872
Closed -$20K
PED icon
6057
PEDEVCO
PED
$141M
-352
Closed -$11K
PEJ icon
6058
Invesco Leisure and Entertainment ETF
PEJ
$308M
-39,152
Closed -$2.05M
PESI icon
6059
Perma-Fix Environmental Services
PESI
$383M
-123
Closed -$1K
PFD
6060
Flaherty & Crumrine Preferred and Income Fund
PFD
$146M
$0 ﹤0.01%
+8
New +$131
PFLT icon
6061
PennantPark Floating Rate Capital
PFLT
$746M
-434
Closed -$6K
PGP
6062
PIMCO Global StockPLUS & Income Fund
PGP
$100M
-114
Closed -$1K
PHAR
6063
Pharming Group
PHAR
$775M
-89
Closed -$1K
PHIO icon
6064
Phio Pharmaceuticals
PHIO
$12.1M
-6
Closed -$2K
PHT
6065
DELISTED
Pioneer High Income Fund
PHT
$0 ﹤0.01%
+5
New +$51
PHUN icon
6066
Phunware
PHUN
$43.6M
-17
Closed -$1K
PILL icon
6067
Direxion Daily Pharmaceutical & Medical Bull 3X ETF
PILL
$22.8M
-10,562
Closed -$250K
PKX icon
6068
POSCO
PKX
$17.5B
-300
Closed -$23K
PLAG icon
6069
Planet Green Holdings
PLAG
$8M
$0 ﹤0.01%
+21
New +$282
PLBC icon
6070
Plumas Bancorp
PLBC
$429M
-531
Closed -$17K
PLX icon
6071
Protalix BioTherapeutics
PLX
$198M
-4,658
Closed -$9K
POLA icon
6072
Polar Power
POLA
$6.86M
-1
Closed
PPSI
6073
Pioneer Power Solutions
PPSI
$34.3M
-427
Closed -$2K
PPT
6074
Franklin Premier Income Trust
PPT
$328M
$0 ﹤0.01%
+22
New +$101
PRFZ icon
6075
Invesco FTSE RAFI US 1500 Small-Mid ETF
PRFZ
$2.88B
-26,945
Closed -$1.01M

Similar funds

Tower Research Capital (TRC)'s Q3 2021 Portfolio in Review

As of Q3 2021, Tower Research Capital (TRC) held 6,700 positions worth $3.92B, up 2% from $3.84B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Tower Research Capital (TRC) deployed $135M of net new capital in Q3 2021, opening 1,026 new positions and adding to 2,252 existing holdings. Its largest new stake was Vanguard S&P 500 ETF: 107,857 shares worth $42.5M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was UnitedHealth, an estimated $19.9M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2021 buy was Vanguard S&P 500 ETF: 107,857 shares worth $42.5M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $342M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2021 reduction was UnitedHealth, cutting an estimated $19.9M.
  • Tower Research Capital (TRC) fully exited iShares Semiconductor ETF in Q3 2021, selling an estimated $19M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 32% of its $3.92B portfolio in Q3 2021.
  • Tower Research Capital (TRC) opened 1,026 new positions and closed 691 in Q3 2021.
  • Tower Research Capital (TRC)'s portfolio value rose 2% quarter-over-quarter to $3.92B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2021, filed 15 Nov 2021.